Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Non-cash Items (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Non-cash Items for 5 consecutive years, with $4.7 million as the latest value for Q1 2026.

  • For Q1 2026, Non-cash Items fell 72.27% year-over-year to $4.7 million; the TTM value through Mar 2026 reached $4.7 million, down 72.27%, while the annual FY2025 figure was $80.5 million, 2671.5% up from the prior year.
  • Non-cash Items hit $4.7 million in Q1 2026 for Phathom Pharmaceuticals, down from $80.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $80.5 million in Q4 2025 and bottomed at $170000.0 in Q1 2023.
  • Average Non-cash Items over 5 years is $13.7 million, with a median of $4.5 million recorded in 2025.
  • Year-over-year, Non-cash Items plummeted 97.24% in 2023 and then soared 3674.45% in 2025.
  • Phathom Pharmaceuticals' Non-cash Items stood at $4.5 million in 2022, then dropped by 24.51% to $3.4 million in 2023, then tumbled by 36.87% to $2.1 million in 2024, then skyrocketed by 3674.45% to $80.5 million in 2025, then crashed by 94.11% to $4.7 million in 2026.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $4.7 million, $80.5 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.